Australia, Aug. 13 -- Nuvalent Inc., owns the trademark (2551894) for 'ZENROSIB' till April 18, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders.]
Type of Mark: Word
Date of Acceptance: June 5
Registration Advertised: Aug. 12
For further details contact Joshua S. Jarvis Foley Hoag LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2551894.
Disclaimer: Curated by HT Syndication.
